Melanin‐Like Nanomedicine Functions as a Novel RPE Ferroptosis Inhibitor to Ameliorate Retinal Degeneration and Visual Impairment in Dry Age‐Related Macular Degeneration DOI

Keke Huang,

Hongkuan Deng,

Shuang Wang

и другие.

Advanced Healthcare Materials, Год журнала: 2024, Номер 13(30)

Опубликована: Авг. 11, 2024

Ferrous ion accumulation and lethal oxidative stress mediate irreversible retinal pigment epithelial (RPE) cell ferroptosis subsequent photoreceptor degeneration, a potential key pathogenic factor in the onset of dry age-related macular degeneration (dAMD), causing vision loss global elderly population. However, currently, no effective interventional treatment strategy exists clinical practice. Herein, lesion site-targeted melanin-like nanoparticles, named ConA-MelNPs, are designed as novel inhibitor for degenerative diseases. ConA-MelNPs possessed chelating iron characteristics, alleviating severe mitochondrial damage caused by protecting RPE cells from induced sodium iodate (NaIO

Язык: Английский

Extracellular vesicles and their engineering strategies, delivery systems, and biomedical applications DOI
Chunhao Yang,

Yunxin Xue,

Yu Duan

и другие.

Journal of Controlled Release, Год журнала: 2024, Номер 365, С. 1089 - 1123

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

43

Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks DOI
Popat Kumbhar,

Kaustubh Kolekar,

Sukriti Vishwas

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 98, С. 102322 - 102322

Опубликована: Май 8, 2024

Язык: Английский

Процитировано

14

Co-delivery of antioxidants and siRNA-VEGF: promising treatment for age-related macular degeneration DOI
Marina França Dias, Estael Luzia Coelho da Cruz-Cazarim, Frederico Pittella

и другие.

Drug Delivery and Translational Research, Год журнала: 2025, Номер unknown

Опубликована: Янв. 3, 2025

Язык: Английский

Процитировано

1

Mesenchymal stem cells and mesenchymal stem cell-derived exosomes: a promising strategy for treating retinal degenerative diseases DOI Creative Commons

Wenjing An,

Wenliang Zhang, Qi Jia

и другие.

Molecular Medicine, Год журнала: 2025, Номер 31(1)

Опубликована: Фев. 21, 2025

Abstract Mesenchymal stem cells (MSCs) have emerged as a promising therapeutic strategy in regenerative medicine, demonstrating significant potential for clinical applications. Evidence suggests that MSCs not only exhibit multipotent differentiation but also exert critical effects retinal degenerative diseases via robust paracrine mechanisms. protect from damage by modulating inflammation, inhibiting apoptosis, alleviating oxidative stress, and suppressing cell death pathways. Furthermore, contribute to structural functional stability facilitating vascular remodeling donating mitochondria cells. Of particular interest, MSC-derived exosomes gained widespread attention compelling cell-free therapy. Owing their potent anti-inflammatory, anti-apoptotic, vascular-stabilizing properties, show promise the treatment of diseases.

Язык: Английский

Процитировано

1

The significance of precisely regulating heme oxygenase-1 expression: Another avenue for treating age-related ocular disease? DOI
Wei Dong,

Chengkang Qu,

Na Zhao

и другие.

Ageing Research Reviews, Год журнала: 2024, Номер 97, С. 102308 - 102308

Опубликована: Апрель 12, 2024

Язык: Английский

Процитировано

7

Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases DOI Creative Commons
Yun Su,

Moxin Chen,

Wei Xu

и другие.

ACS Nano, Год журнала: 2024, Номер 18(34), С. 22793 - 22828

Опубликована: Авг. 14, 2024

Extracellular vesicles (EVs) are nanoscale membrane of various sizes that can be secreted by most cells. EVs contain a diverse array cargo, including RNAs, lipids, proteins, and other molecules with functions intercellular communication, immune modulation, regulation physiological pathological processes. The biofluids in the eye, tears, aqueous humor, vitreous important sources for EV-based diagnosis ocular disease. Because molecular cargos may reflect biology their parental cells, these biofluids, as well blood, have been recognized promising candidates biomarkers early Moreover, also used therapeutics targeted drug delivery nanocarriers many disorders because low immunogenicity superior biocompatibility nature. In this review, we provide an overview recent advances field studies on We summarized origins applied disease, assessed different methods EV isolation from biofluid samples, highlighted bioengineering strategies systems, introduced latest applications treatment presented potential current clinical trials. Finally, briefly discussed challenges disease some issues concern better focusing translational future.

Язык: Английский

Процитировано

6

Emerging role of mesenchymal stem cells-derived extracellular vesicles in vascular dementia DOI Creative Commons
Ziying Liu, Lin Cheng, Lushun Zhang

и другие.

Frontiers in Aging Neuroscience, Год журнала: 2024, Номер 16

Опубликована: Фев. 8, 2024

Vascular dementia (VD) is a prevalent cognitive disorder among the elderly. Its pathological mechanism encompasses neuronal damage, synaptic dysfunction, vascular abnormalities, neuroinflammation, and oxidative stress, others. In recent years, extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) have garnered significant attention as an emerging therapeutic strategy. Current research indicates that MSC-derived (MSC-EVs) play pivotal role in both diagnosis treatment of VD. Thus, this article delves into advancements MSC-EVs VD, discussing mechanisms by which EVs influence pathophysiological processes These form theoretical foundation for their neuroprotective effect VD treatment. Additionally, highlights potential applications diagnosis. conclusion, present promising innovative strategy With rigorous ongoing innovation, concept can transition practical clinical treatment, providing more effective options patients.

Язык: Английский

Процитировано

5

Age-Related Macular Degeneration (AMD): Pathophysiology, Drug Targeting Approaches, and Recent Developments in Nanotherapeutics DOI Creative Commons
Mahendra Pratap Singh,

Riyakshi Negi,

Alka

и другие.

Medicina, Год журнала: 2024, Номер 60(10), С. 1647 - 1647

Опубликована: Окт. 8, 2024

The most prevalent reason for vision impairment in aging inhabitants is age-related macular degeneration (AMD), a posterior ocular disease with poor understanding of the anatomic, genetic, and pathophysiological progression disease. Recently, new insights exploring role atrophic changes retinal pigment epithelium, extracellular drusen deposits, lysosomal lipofuscin, various genes have been investigated AMD. Hence, this review explores incidence risk factors AMD, such as oxidative stress, inflammation, complement system, involvement bioactive lipids their angiogenesis. In addition to intravitreal anti-vascular endothelial growth factor (VEGF) therapy other therapeutic interventions oral kinase inhibitors, photodynamic, gene, antioxidant therapy, well benefits drawbacks AMD treatment options, strategic drug delivery methods, including routes focus on pharmacokinetics, are investigated. Further, recent advancements nanoformulations polymeric lipid nanocarriers, liposomes, etc., intended pros cons too summarized. Therefore, purpose give researchers an pathophysiology, emphasis angiogenesis, function lipids, options. Additionally, options that development system(s) via several can aid advancement choices.

Язык: Английский

Процитировано

5

Induced pluripotent stem cell-derived mesenchymal stem cells: whether they can become new stars of cell therapy DOI Creative Commons
Zewen Wu, Yazhen Su, Jingxuan Li

и другие.

Stem Cell Research & Therapy, Год журнала: 2024, Номер 15(1)

Опубликована: Окт. 16, 2024

Stem cell therapy constitutes a pivotal subject in contemporary discourse, with donor stem cells having been employed research and clinical treatments for several decades. Primary transplantation encompasses diverse types, including ectomesenchymal cells, hematopoietic various derivatives such as vesicles extracellular vesicles. Nevertheless, the emergence of engineering techniques has heralded new epoch therapy, markedly broadening their therapeutic potential. Induced pluripotent (iPSCs) epitomize significant milestone modern medical biology. This groundbreaking discovery offers potential disciplines biology, pathophysiology, cellular regenerative medicine. As result, iPSCs derived differentiated have become pioneering avenue research. mesenchymal (iMSCs), from iPSCs, represent novel frontier MSCs related Empirical evidence suggests that iMSCs demonstrate enhanced proliferative capacities compared to natural MSCs, diminished age-related variability heterogeneity. Numerous trials highlighted prospective superiority iMSCs. article synthesizes current basic pertaining iMSCs, aiming provide reference point future endeavors.

Язык: Английский

Процитировано

5

Mechanism of mesenchymal stem cells and exosomes in the treatment of age-related diseases DOI Creative Commons
Jia Li,

Yuling Huang,

Haiyan Sun

и другие.

Frontiers in Immunology, Год журнала: 2023, Номер 14

Опубликована: Май 18, 2023

Mesenchymal stem cells (MSCs) from multiple tissues have the capability of multidirectional differentiation and self-renewal. Many reports indicated that MSCs exert curative effects on a variety age-related diseases through regeneration repair aging organs. However, as research has progressed, it become clear is derived exosomes (MSC-Exos) may real role to play, they can be modified achieve better therapeutic results, making them even more advantageous than for treating disease. This review generalizes biological characteristics their mechanisms in diseases, example, treat such oxidative stress (OS), Wnt/β-catenin signaling pathway, mitogen-activated protein kinases (MAPK) so on. In addition, current vivo vitro trials are described, ongoing clinical discussed, well prospects challenges future use disease treatment. will provide references using diseases.

Язык: Английский

Процитировано

11